Dog Vaccines Market Outlook Indicating Growth to $5.4 Billion by 2030
The Business Research Company’s 2026 market reports include new capabilities such as market attractiveness scoring and analysis, total addressable market analysis, company scoring matrix, interactive excel data dashboard, improved supply chain analysis, upcoming startups in the market, and overview of key products, aimed at improving the depth, usability, and strategic value of the insights delivered.
What Market Size Increase Is Anticipated For The Anakinra Market Over The 2026–2030 Period?
The dog vaccines market size has shown substantial growth over recent years. It is expected to expand from $3.8 billion in 2025 to $4.07 billion in 2026, demonstrating a compound annual growth rate (CAGR) of 7.2%. The historical increase in this market can be linked to a rise in the global dog population, increased awareness of canine diseases, the introduction of innovative vaccine types, advancements in veterinary healthcare infrastructure, and the rising prevalence of infectious canine diseases.
The dog vaccines market is expected to demonstrate significant expansion in the next few years. It is projected to achieve a size of $5.44 billion by 2030, growing at a compound annual growth rate (CAGR) of 7.5%. This growth during the forecast period is attributable to breakthroughs in recombinant and DNA vaccines, a stronger emphasis on preventive healthcare for canines, the widening scope of veterinary immunization programs, increased investments in canine health research and development, and the adoption of digital instruments for tracking vaccinations. Prominent trends anticipated in the forecast period include a rise in vaccination awareness among dog owners, the creation of multivalent vaccines for canines, an increase in the adoption of preventive veterinary care, the expansion of vaccination schedules for pediatric and adult canines, and the growth in veterinary clinics offering extensive immunization services.
Download the Free Sample Report to Explore Key Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=8443&type=smp
What Underlying Factors Are Accelerating The Growth Of The Anakinra Market?
The increasing occurrence of zoonotic diseases is anticipated to drive the expansion of the dog vaccines market moving forward. Zoonotic diseases, also referred to as zoonoses, are communicable illnesses that can naturally spread between animals and humans, and vice versa. The rise in zoonotic diseases is attributed to human populations encroaching on wildlife habitats, leading to greater interaction with animals and a higher chance of disease transmission. Dog vaccines are essential for preventing the spread of zoonotic diseases from canines to humans, thereby supporting broader public health initiatives to manage and curb zoonotic infections. For example, in February 2023, data from the Council on Foreign Relations (CFR)—an independent, nonpartisan US-based organization, think tank, and publisher—indicated that up to 75% of newly identified or emerging infectious diseases (EIDs) and 60% of known infectious diseases originate from zoonoses. Globally, zoonoses are responsible for 2.7 million human deaths and 2.5 billion disease incidents annually. Consequently, the increasing prevalence of zoonotic diseases is propelling the expansion of the dog vaccines market.
How Is The Anakinra Market Segmented Across Key Categories?
The dog vaccines market covered in this report is segmented –
1) By Type: Attenuated Live Vaccines, Conjugate Vaccines, Inactivated Vaccines, Subunit Vaccines, Toxoid Vaccines, DNA Vaccines, Recombinant Vaccines
2) By Route Of Administration: Subcutaneous, Intramuscular, Intranasal
3) By Application: Below 6 Months, Above 6 Months
Subsegments:
1) By Attenuated Live Vaccines: Canine Parvovirus Vaccine, Canine Distemper Vaccine, Canine Adenovirus Vaccine
2) By Conjugate Vaccines: Canine Leptospira Vaccine, Canine Bordetella Vaccine
3) By Inactivated Vaccines: Canine Parvovirus Vaccine, Canine Influenza Vaccine
4) By Subunit Vaccines: Canine Lyme Disease Vaccine, Canine Parainfluenza Vaccine
5) By Toxoid Vaccines: Canine Leptospirosis Toxoid Vaccine
6) By DNA Vaccines: Canine Melanoma Vaccine
7) By Recombinant Vaccines: Canine Lyme Disease Recombinant Vaccine, Canine Bordetella Recombinant Vaccine
Which Upcoming Trends Are Expected To Influence The Dog Vaccines Market?
Leading companies in the dog vaccines market are concentrating on creating innovative vaccine technologies, such as next-generation recombinant and RNA-based vaccines, to enhance immune response, safety, and duration of protection for companion animals. Next-generation canine vaccines are engineered to stimulate specific immunity using modern platforms, while recombinant vaccines utilize particular antigens to minimize adverse reactions and boost effectiveness. For example, in June 2024, the United States Department of Agriculture (USDA) granted approval to Nobivac NXT Canine Influenza Virus (CIV), a next-generation RNA-particle vaccine for dogs, from Merck & Co. Inc.’s MSD Animal Health, a US-based animal health company. This approval represents a notable step forward in preventing canine influenza by offering rapid onset of immunity and improved protection against circulating virus strains.
Who Are The Dominant Players Shaping The Anakinra Market Landscape?
Major companies operating in the dog vaccines market are Vetoquinol S.A., Boehringer Ingelheim GmbH, Ceva Sante Animale, Heska Corporation, Merck & Co. Inc., Virbac Animal Health Pvt. Ltd., Elanco Animal Health Incorporated, Zoetis Inc., CZ Vaccines, Indian Immunologicals Ltd., Meiji Holdings Co. Ltd., Bioveta A.S., Phibro Animal Health Corporation, Hester Biosciences Limited, Dechra Pharmaceuticals PLC, Norbrook Inc., Biogenesis Bago SA, Vaxxinova India Private Limited, Bimeda Animal Health Ltd., Lohmann Animal Health GmbH, Biovac Ltd., Zenex Animal Health India Pvt. Ltd., Instituto Rosenbusch S.A.
Read the full dog vaccines market report here:
https://www.thebusinessresearchcompany.com/report/dog-vaccines-global-market-report
Which Region Is Projected To Dominate The Anakinra Market During The Forecast Period?
Asia-Pacific was the largest region in the dog vaccines market in 2025. The regions covered in the dog vaccines market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Request A Tailored Anakinra Market Research Report For Competitive Advantage:
https://www.thebusinessresearchcompany.com/customise?id=8443&type=smp
Browse Through More Reports Similar to the Global Dog Vaccines Market 2026, By The Business Research Company
Veterinary Vaccines Global Market Report 2026
https://www.thebusinessresearchcompany.com/report/veterinary-vaccines-global-market-report
Companion Animal Veterinary Vaccines Global Market Report 2026
Vaccines Global Market Report 2026
https://www.thebusinessresearchcompany.com/report/vaccines-global-market-report
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
